ReviewLife (Basel, Switzerland)2026
Zilebesiran, a Small Interfering RNA Therapeutic Targeting Angiotensinogen: Mechanism, Clinical Evidence, Safety, and Implementation Considerations.
Jawaria et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.